Contact
Please use this form to send email to PR contact of this press release:
Phase 3 study with filgotinib initiated in Crohn's disease
TO:
Please use this form to send email to PR contact of this press release:
Phase 3 study with filgotinib initiated in Crohn's disease
TO: